Overview

• The family’s GoFundMe has raised €200,000 toward its €1.5 million goal, driven by donations from Antonio Conte, Simone Inzaghi and support from Zlatan Ibrahimović
• Columbia University and a San Diego laboratory have begun preclinical development of a personalized antisense oligonucleotide therapy targeting Materazzi’s TDP-43 ALS mutation
• Marco Materazzi plans a charity match at Rome’s Stadio Olimpico featuring the 2006 Italy squad against an All-Star team to further boost research funding
• Diagnosed in September 2024 after Claudio Marchisio noticed his abnormal gait and Prof. Sabatelli confirmed ALS, Materazzi now relies on full assistance for daily tasks
• The family has spent €100,000 on daily care with only partial support from the local health authority, highlighting the steep costs of ALS management